Clinical Trials
9 trialsNCT04983901 2026-04-06
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03269994 2025-10-21
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT06422533 2024-06-04
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Instituto Nacional de Cancerologia de Mexico
Phase NA Recruiting
NCT04394182 2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA Suspended
NCT03485950 2022-03-15
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02732327 2017-07-21
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Forest Laboratories
Phase 2 Terminated
NCT02463747 2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT00003805 2012-09-24
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00044759 2007-10-10
Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3 Completed